Development of an Evidence-Based List of Noncytotoxic Vesicant Medications and Solutions
- 1 January 2017
- journal article
- features
- Published by Wolters Kluwer Health in Journal of Infusion Nursing
- Vol. 40 (1) , 26-40
Abstract
Infiltration of a vesicant medication, defined as extravasation, may result in significant patient injuries. The first step in preventing extravasation is the identification and recognition of vesicant medications and solutions. Because there is no list of noncytotoxic vesicants as established by a professional organization, the Infusion Nurses Society, as the global authority in infusion nursing, identified the need to address this gap. A task force was formed for the purpose of creating an evidence-based list of noncytotoxic vesicant medications and solutions.Keywords
This publication has 18 references indexed in Scilit:
- Safe Administration of Vancomycin through a Novel Midline Catheter: A Randomized, Prospective Clinical TrialThe Journal of Vascular Access, 2014
- Extravasation of Noncytotoxic DrugsAnnals of Pharmacotherapy, 2014
- A.S.P.E.N. Clinical GuidelinesJournal of Parenteral and Enteral Nutrition, 2014
- Management of Extravasation Injuries: A Focused Evaluation of Noncytotoxic MedicationsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2014
- Identification of highly concentrated dextrose solution (50% dextrose) extravasation and treatment—a clinical reportThe American Journal of Emergency Medicine, 2013
- Reducing Risk of Harm From ExtravasationJournal of Infusion Nursing, 2013
- Bullous Dermatosis Associated With Vancomycin ExtravasationThe American Journal of the Medical Sciences, 2012
- Intravenous Administration IssuesJournal of Infusion Nursing, 2010
- Infiltration and ExtravasationJournal of Infusion Nursing, 2009
- Severe local vancomycin induced skin necrosisBritish Journal of Clinical Pharmacology, 2007